Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan Ko
Jonathan Ko
German Cancer Research Center
Medicine
Multiple myeloma
Therapeutic index
Antibody-drug conjugate
Antibody
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
HDP-101, anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells.
2020
Molecular Cancer Therapeutics
Vianihuini Figueroa-Vazquez
Jonathan Ko
Christian Breunig
Anja Baumann
Nicola Giesen
Anikó Pálfi
Christoph Müller
Christian Lutz
Torsten Hechler
Michael Kulke
Carsten Müller-Tidow
Alwin Krämer
Hartmut Goldschmidt
Andreas Pahl
Marc S. Raab
Show All
Source
Cite
Save
Citations (14)
HDP-101: Preclinical evaluation of a novel anti-BCMA antibody drug conjugates in multiple myeloma.
2018
Journal of Clinical Oncology
Andreas Pahl
Jonathan Ko
Christian Breunig
Vianiuhini Figueroa
Nicola Lehners
Anja Baumann
Anikó Pálfi
Christoph Mueller
Christian Lutz
Torsten Hechler
Michael Kulke
Carsten Mueller-Tidow
Hartmut Goldschmidt
Marc S. Raab
Show All
Source
Cite
Save
Citations (11)
Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma
2017
Blood
Jonathan Ko
Christian Breunig
Vianiuhini Figueroa
Nicola Lehners
Anja Baumann
Anikó Pálfi
Christoph Müller
Christian Lutz
Torsten Hechler
Michael Kulke
Carsten Müller-Tidow
Hartmut Goldschmidt
Andreas Pahl
Marc S. Raab
Show All
Source
Cite
Save
Citations (9)
1